Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Memorial Sloan Kettering Cancer Center
Columbia University
Abramson Cancer Center at Penn Medicine
Peking University First Hospital
St. Jude Children's Research Hospital
University Hospital, Rouen
Asan Medical Center
Laikο General Hospital, Athens
Masonic Cancer Center, University of Minnesota
Peking Union Medical College Hospital
St. Jude Children's Research Hospital
The University of Texas Health Science Center at San Antonio
Central Hospital, Nancy, France
Nanjing First Hospital, Nanjing Medical University
Peking University First Hospital
AC Camargo Cancer Center
University of Wuerzburg
Fudan University
First Affiliated Hospital of Zhejiang University
University of Pennsylvania
Grupo Espanol de Tumores Neuroendocrinos
British Columbia Cancer Agency
Seoul National University Hospital
Cancer Research UK